| SC 13G/A | 2018-01-25 | BlackRock Inc. | LILLY ELI & CO | 63,854,112 | 5.8% | EDGAR |
| SC 13G/A | 2018-01-17 | LILLY ENDOWMENT INC | LILLY ELI & CO | 123,075,804 | 11.2% | EDGAR |
| SC 13G | 2017-11-22 | LILLY ELI & CO | LEAP THERAPEUTICS, INC. | 2,301,000 | 17.5% | EDGAR |
| SC 13G/A | 2017-06-07 | LILLY ELI & CO | Ignyta, Inc. | 1,886,777 | 3.4% | EDGAR |
| SC 13D/A | 2017-03-01 | LILLY ELI & CO | CoLucid Pharmaceuticals, Inc. | 100 | 100.0% | EDGAR |
| SC 13G/A | 2017-02-09 | VANGUARD GROUP INC | LILLY ELI & CO | 66,415,305 | 6.0% | EDGAR |
| SC 13G/A | 2017-02-09 | PRIMECAP MANAGEMENT CO/CA/ | LILLY ELI & CO | 57,501,098 | 5.2% | EDGAR |
| SC 13G | 2017-02-09 | WELLINGTON MANAGEMENT GROUP LLP | LILLY ELI & CO | 56,814,140 | 5.2% | EDGAR |
| SC 13D | 2017-01-27 | LILLY ELI & CO | CoLucid Pharmaceuticals, Inc. | 54,683 | 35.0% | EDGAR |
| SC 13G/A | 2017-01-24 | BlackRock Inc. | LILLY ELI & CO | 62,755,539 | 5.7% | EDGAR |
| SC 13G/A | 2017-01-13 | LILLY ENDOWMENT INC | LILLY ELI & CO | 125,575,804 | 11.4% | EDGAR |
| SC 13G | 2016-04-22 | LILLY ELI & CO | LILLY ELI & CO | 2,568,543 | 19.2% | EDGAR |
| SC 13G/A | 2016-02-12 | PRIMECAP MANAGEMENT CO/CA/ | LILLY ELI & CO | 57,654,392 | 5.2% | EDGAR |
| SC 13G/A | 2016-02-11 | WELLINGTON MANAGEMENT GROUP LLP | LILLY ELI & CO | 44,848,098 | 4.0% | EDGAR |
| SC 13G | 2016-02-11 | VANGUARD GROUP INC | LILLY ELI & CO | 59,913,179 | 5.4% | EDGAR |
| SC 13G/A | 2016-02-10 | BlackRock Inc. | LILLY ELI & CO | 66,007,964 | 6.0% | EDGAR |
| SC 13G/A | 2016-01-12 | LILLY ENDOWMENT INC | LILLY ELI & CO | 127,860,804 | 11.5% | EDGAR |
| SC 13G | 2015-11-16 | LILLY ELI & CO | Ignyta, Inc. | 2,713,000 | 8.4% | EDGAR |
| SC 13G/A | 2015-02-17 | LILLY ELI & CO | Receptos, Inc. | 967,067 | 3.1% | EDGAR |
| SC 13G | 2015-02-17 | LILLY ELI & CO | Cerulean Pharma Inc. | 2,356,227 | 11.7% | EDGAR |